US OptionsDetailed Quotes
TEVA240809P20000
- 2.59
- -0.76-22.69%
15min DelayClose Aug 9 16:00 ET
2.59High2.56Low
2.56Open3.35Pre Close2 Volume2 Open Interest20.00Strike Price515.00Turnover1064.74%IV0.11%PremiumAug 9, 2024Expiry Date2.57Intrinsic Value100Multiplier-1DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.9012Delta0.0972Gamma6.58Leverage Ratio-4.4844Theta0.0000Rho-5.93Eff Leverage0.0003Vega
Teva Pharmaceutical Industries Stock Discussion
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX – Research Report), Eli Lilly & Co (LLY – Research Report) and Teva Pharmaceutical (TEVA – Research Report) with bullish sentiments.
Immuneering (IMRX)
In a report issued on A...
$Air Products & Chemicals (APD.US)$ : “You really don’t want to be in Air Products, you want to be in Linde. Linde’s a much better run company, and that’s why Air Products isn’t doing as well , and Linde’s doing spectacularly.”
$Sarepta Therapeutics (SRPT.US)$ : “I think Sarepta is a speculative situation where they have great science. ...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
loading...
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
No comment yet